About Precise Bio
Precise Bio is a company based in Winston-salem (United States) founded in 2015 by Shay Soker, Aryeh Batt, and Anthony Atala.. Precise Bio has raised $12 million across 3 funding rounds from investors including ZEISS. The company has 6 employees as of December 31, 2022. Precise Bio offers products and services including Precise Bio Platform and Ophthalmology Unit. Precise Bio operates in a competitive market with competitors including Nuclera Nucleics, CELLINK, Collplant, Triastek and ROKIT Healthcare, among others.
- Headquarter Winston-salem, United States
- Employees 6 as on 31 Dec, 2022
- Founders Shay Soker, Aryeh Batt, Anthony Atala
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precise Bio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12 M (USD)
in 3 rounds
-
Latest Funding Round
$12 M (USD), Series B
Jan 17, 2024
- Investors
-
Employee Count
6
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precise Bio
Precise Bio offers a comprehensive portfolio of products and services, including Precise Bio Platform and Ophthalmology Unit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrated system for bio-fabricating tissues and organs using patient cells.
Dedicated unit for eye-related bio-fabrication and tissue engineering.
Unlock access to complete
Unlock access to complete
Funding Insights of Precise Bio
Precise Bio has successfully raised a total of $12M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $12 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $12.0M
-
First Round
First Round
(08 Feb 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series B - Precise Bio | Valuation |
investors |
|
| Jul, 2022 | Amount | Seed - Precise Bio | Valuation | ZEISS |
|
| Feb, 2022 | Amount | Debt – Conventional - Precise Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Precise Bio
Precise Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ZEISS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of diversified optics for microscopic instruments, medical imaging systems and more
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precise Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Precise Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precise Bio Comparisons
Competitors of Precise Bio
Precise Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, CELLINK, Collplant, Triastek and ROKIT Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing pharmaceutical technology platform for drug design
|
|
| domain | founded_year | HQ Location |
4D bio-printer solutions for tissue regeneration are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precise Bio
Frequently Asked Questions about Precise Bio
When was Precise Bio founded?
Precise Bio was founded in 2015 and raised its 1st funding round 7 years after it was founded.
Where is Precise Bio located?
Precise Bio is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Who is the current CEO of Precise Bio?
Aryeh Batt is the current CEO of Precise Bio. They have also founded this company.
Is Precise Bio a funded company?
Precise Bio is a funded company, having raised a total of $12M across 3 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $15.53M, raised on Feb 08, 2022.
How many employees does Precise Bio have?
As of Dec 31, 2022, the latest employee count at Precise Bio is 6.
What does Precise Bio do?
Precise Bio was founded in 2015 in Winston-Salem, United States. An integrated 3D printing and tissue-engineering platform is developed for the regenerative medicine sector. Repeatable bio-fabricated organs are produced from patients own cells, targeting cardiology, orthopedics, dermatology, and additional areas. The lead product, a 3D cardiac tissue patch, is implanted post-myocardial infarction to restore cardiac muscle viability and functionality.
Who are the top competitors of Precise Bio?
Precise Bio's top competitors include Nuclera Nucleics, Allevi and Collplant.
What products or services does Precise Bio offer?
Precise Bio offers Precise Bio Platform and Ophthalmology Unit.
Who are Precise Bio's investors?
Precise Bio has 1 investor. Key investors include ZEISS.